Burt A. Adelman

This profile gathers the share dealings of Burt A. Adelman across 2 companies, led by Dyax Corp and Verve Therapeutics, Inc. Over a trading history stretching from 13 January 2016 to 25 July 2025, the count stands at 8 filings.

Purchases make up the whole of the open-market record (3 purchases, €325k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 option exercises.

A typical purchase (the median) is worth €117k. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 28 July 2025: a transaction, in Verve Therapeutics, Inc. The last purchase on record was published on 13 May 2022, which is 1,619 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.